Cuadero, Ronald A.

HRN: 29-48-13  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/13/2026
08/20/2026
IV
500 MG
Q8
PENETRATING INJURY EPIGASTRIC AREA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: